Allergy immunotherapy: reduced health care costs in adults and children with allergic rhinitis
CS Hankin, L Cox, A Bronstone, Z Wang - Journal of allergy and clinical …, 2013 - Elsevier
BACKGROUND: Research demonstrates significant health care cost savings conferred by
allergen-specific immunotherapy (AIT) to US children with allergic rhinitis (AR). OBJECTIVE:
We sought to examine whether AIT-related cost benefits conferred to US children with AR
similarly extend to adults. METHODS: A retrospective (1997-2009) Florida Medicaid claims
analysis compared mean 18-month health care costs of patients with newly diagnosed AR
who received de novo AIT and were continuously enrolled for 18 months or more versus …
allergen-specific immunotherapy (AIT) to US children with allergic rhinitis (AR). OBJECTIVE:
We sought to examine whether AIT-related cost benefits conferred to US children with AR
similarly extend to adults. METHODS: A retrospective (1997-2009) Florida Medicaid claims
analysis compared mean 18-month health care costs of patients with newly diagnosed AR
who received de novo AIT and were continuously enrolled for 18 months or more versus …